Ophthalmic Lasers Market Is Likely to Be Valued at Us$ 1.3 Bn by 2030-end, Expanding at a Cagr of 5%

Leading players in the ophthalmic laser market are investing increasingly in laser refractive surgical procedures, owing to high success rates and superior operational outcomes. The growing geriatric population, increasing initiatives for treatment of vision impairment, and increasing prevalence of various chronic ophthalmic disorders are expected to drive the ophthalmic lasers market over the predicted years

The ophthalmic lasers market is expected to reach a US$ 1.3 billion by the end of the assessing period between the years 2020 and 2030. The coronavirus pandemic has resulted in a significant short-term downturn in the requirement for ophthalmic lasers. Lockdown restrictions have limited supply and distribution capabilities. In addition, restrictive guidelines on elective medical procedures will hurt demand in the near term. However, recovery is likely to be strong towards 2021.

“The rate of partial or complete blindness has risen substantially in the recent past and is expected to continue growing well into the coming decade. These issues are further compounded by growing cases of glaucoma, cataract, and diabetes, which will provide growth opportunities to ophthalmic laser manufacturers,” says the FMI report.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Ophthalmic Lasers – Primary Takeaways

Ophthalmic Lasers – Growth Factors

• Growth in the regulatory approvals of new ophthalmic laser devices and treatments are beneficial for market prospects.
• Sustained growth in investments for healthcare infrastructure drives sales and use of ophthalmic lasers.

Ophthalmic Lasers – Major Constraints

• Lack of awareness about ophthalmic laser treatment options, particularly in rural areas are holding back market growth.
• High costs associated with ocular laser treatments is hindering adoption of related equipment.

The Projected Impact of Coronavirus

Ophthalmic medical procedures and around the world have been postponed or severely curtailed in many parts of the world under lockdown regulations during the coronavirus pandemic. Further, supply and distribution channels for ophthalmic laser manufacturers are facing challenges in terms of logistics and transport. These factors are expected to hinder growth of the market in the short term. However, demand is likely to recovery steadily towards 2021 helping clear the backlog of ocular ailment treatments.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1529

Competition Landscape

The ophthalmic lasers market comprises players including but not limited to NKT Photonics A/S, Zeiss International, iVIS Technologies, Nidek Inc., Lensar LLC, Bausch & Lomb Inc., Novartis AG, Abbott Laboratories, Zeimer Ophthalmic Systems AG, and SCHWIND Eye-Tech Solutions.

Players operating in the ophthalmic lasers market have been increasingly invested in widening their product portfolios with acquisition and long-term product development strategies, for a wider range of treatments.

For instance, ELT Sight has announced its acquisition of the IP and assets of excimer ophthalmic laser systems from MLase AG. Schwind eye-tech solutions has received the approval of European CE certification for its ATOS femtosecond laser. Further, the Fyodorov Eye Microsurgery Complex has unveiled a new laser-based artificial eye-lens replacement surgery, aimed towards improving regeneration.